Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY ISSUE OF JUNE 10, 2009 FBO #2753
SOLICITATION NOTICE

66 -- UV/Visible Spectrometer

Notice Date
6/8/2009
 
Notice Type
Combined Synopsis/Solicitation
 
NAICS
334516 — Analytical Laboratory Instrument Manufacturing
 
Contracting Office
Department of Health and Human Services, Food and Drug Administration, Office of Acquisitions and Grants Services, 5630 Fishers Lane, Room 2129, Rockville, Maryland, 20857-0001
 
ZIP Code
20857-0001
 
Solicitation Number
FDA-RFQ-09-1057460
 
Point of Contact
Karen R. Petty, Phone: 301-827-8774
 
E-Mail Address
karen.petty@fda.hhs.gov
(karen.petty@fda.hhs.gov)
 
Small Business Set-Aside
Total Small Business
 
Description
Synopsis: This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in FAR 12.6. This announcement constitutes the only solicitation and a written solicitation will not be issued. This synopsis, NAICS code 334516, is to notify contractors that the Food and Drug Administration (FDA) is seeking competition of this requirement in accordance with FAR Part 13.106 for the following specifications, under the simplified acquisition procures. Under the simplified acquisition procedures and the resultant purchase order will include all applicable provisions and clauses in effect through the Federal Acquisition Circular 05-32. This synopsis is designated for 100% Small Business Set Aside competition for a firm-fixed price purchase order. Prospective offerors are responsible for monitoring the FedBizOpps website for the release of any amendments to this solicitation. Hard copies will be provided to individuals eligible under the Americans with Disabilities Act and Rehabilitation Act upon request. The Government reserves the right to award a contract without discussions if the Contracting Officer determines that the initial offer(s) is/are providing the Best Value and discussions are not necessary. This combined synopsis solicitation is issued as a Request for Quotations (RFQ). The FDA intends to award a purchase order for a Stopped-Flow UV/visible Spectrometer for Kinetic studies. The specifications are as follows: Objective: As part of our project to study the effectiveness of contact lens solutions, we require the use of a UV/visible spectrometer capable of high speed data acquisition coupled to a stopped-flow sample mixing system. Specifications: The necessary system must include at a minimum: •xenon lamp light source •stopped flow mixer with integral absorption/fluorescence cell, drive pneumatics and acquisition initiation trigger •double monochromator based spectrometer capable of true absorption measurements •suitable detector •computer-based control/data acquisition with kinetic analysis software Specification: Source: •non-ozone producing xenon arc lamp with at least 75 watt output and suitable power supply/igniter Monochromator: •Dual beam subtractive double monochromator capable of with a spectral range of 200-700 nm •No more than RMS noise of 0.00030 AU in 0.001 seconds at 450 nm •No more than RMS noise of 0.00005 AU in 0.5 seconds at 550 nm •Acquisition of data at a rate of at least 1000 pts per 0.5 millisecond Detector •Dual fast photomultiplier tubes and twin A/D convertors with acquisition rate of at least 20 MHz and digital resolution of at least 12 bits •Appropriate power supplies and control electronics for PMT-A/D convertors and appropriate interface to data acquisition system Computer •Suitable computer complete with LCD screen, keyboard and mouse, all necessary cabling and interfaces. •Control/analysis software to allow for kinetic analysis. Stopped-flow mixer/cell: •4mm x 4mm path length (set up for absorbance and fluorescence measurements) •Stopped flow reaction volume adjustable between 40 and 120 microliters •Pneumatically driven syringes •Stop syringe to have millisecond range deadtime (before data sampling can occur) •Safety interlocks to prevent actuation without sample or stop syringes being locked in place. •Readily exchanged for conventional sampling cells Place of Delivery: Food and Drug Administration 10903 New Hampshire Avenue Silver Spring, MD 20903 Period of Performance The maintenance/service contract shall include pricing for a base year and four (4) option years. CCR: Vendors must be registered in the Central Contractor Register (CCR) prior to the award of a contract. You may register by going to www.ccr.gov. You will need your Dun & Bradstreet number and banking information. All responsible sources that can provide and meet the above requirements, shall submit written quotation by the response date. QUESTIONS DUE: All questions must be received by email to: karen.petty@fda.hhs.gov, no later than 5:00pm, EST on or before Thursday, June 11, 2009. QUOTATIONS DUE: All quotations must be received by email to: karen.petty@fda.hhs.gov, no later than 5:00pm, EST on or before, Thursday, June 18, 2009. Telephone calls will not be accepted. EVALUATION AND AWARD: Award will be made to the party whose quote offers the best value to the Government, technical, price, and other factors considered. The Government may award this purchase order to other than the lowest price technically acceptable quote. The Government will evaluate information based on the following evaluation criteria: 1) Technical Capability factor "Meeting or Exceeding the Requirement," and 2) Price. Technical Capability is significantly more important than price. The FDA intends to make an award immediately after the response date of this notice. The award will be made in accordance with FAR Part 13, Simplified Acquisition Procedures. PROVISIONS and CLAUSES: The provision at FAR 52.212-1, Instructions to Offerors Commercial Items applies to this solicitation. The following agenda has been attached to this provision: None. Offerors shall include a completed copy of the provision at FAR 52.212-3, Offeror Representations and Certifications Commercial Items. The clause at FAR 52.212-4, Contract Terms and Conditions, Commercial Items applies to this acquisition. The following agenda has been attached to the clause: None. The clause at FAR 52.212-5 Contract Terms and Conditions Required to Implement Statues or Executive Orders, Commercial Items applies to this acquisition. The following FAR clauses cited are applicable: FAR 52.217-8, FAR 52.222-26, FAR 52.222-35, FAR 52.222-36, and FAR 52.232-33. Clauses and provisions are incorporated by reference and apply to this acquisition.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/FDA/DCASC/FDA-RFQ-09-1057460/listing.html)
 
Place of Performance
Address: 10903 New Hampshire Avenue, Silver Spring, Maryland, 20903, United States
Zip Code: 20903
 
Record
SN01838862-W 20090610/090608235116-cc09a56415325afbf43b2f874e9e1831 (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  © 1994-2020, Loren Data Corp.